| Abstrakt: |
A recent study from Amar Telidji University in Algeria explored the potential of two compounds, Strepoxazine A and Taurodispacamide A, from the marine sponge Agelas sp. as inhibitors of key targets in neuroblastoma, a common pediatric solid tumor. Molecular docking analysis indicated that these compounds showed strong inhibition of several important targets in neuroblastoma, suggesting they could be promising therapeutic agents. Further validation through in vitro and in vivo studies is needed to confirm their efficacy and safety for potential use in treating pediatric patients with neuroblastoma. [Extracted from the article] |
